FDA recall, , Low risk
New York Blood Center Enterprises Plasma and Red Blood Cells
Liquid Plasma, collected in an expired collection kit, was distributed.
Recall ended Sep 14, 2026. Still check yours.
What happened
New York Blood Center Enterprises began a recall on January 9, 2026, for multiple blood products collected in expired collection kits. The recalled products include Red Blood Cells, Leukocytes Reduced, Irradiated; Liquid Plasma; Red Blood Cells, Leukocytes Reduced; and Plasma Frozen.
The FDA added the recall to its Enforcement Report on September 14, 2026, and it was listed in the weekly enforcement report on September 23, 2026. The products were distributed in New Jersey, New York, and Rhode Island.
2 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
4 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced, Irradiated
Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, collected in an expired collection kit, were distributed.
Liquid Plasma
Reason: Liquid Plasma, collected in an expired collection kit, was distributed.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected in an expired collection kit, were distributed.
Plasma Frozen
Reason: Plasma Frozen, collected in an expired collection kit, were distributed.
Recall details
- Company began the recall
- Company
- New York Blood Center Enterprises
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99485
- Recall numbers
- B-0234-2026 to B-0237-2026
All recalls from New York Blood Center Enterprises
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated

